Vascular Biogenics, Ltd.-BLOCK

Home » Vascular Biogenics, Ltd.-BLOCK

Secondary

Vascular Biogenics, Ltd.-BLOCK

Vascular Biogenics Ltd., operating as VBL Therapeutics, is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class treatments for cancer.

Symbol

VBLT

Last Closing Price
$9.00

Shares
2,000,000

Effective Date
November 17, 2017

Underwriters
Piper Jaffray

To view the prospectus for Vascular Biogenics, Ltd.-BLOCK, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253